Group | Therapy | Median survival | Volume dosubling time | α [Gy-1] | Tclearance |
Control 1 | Saline | 13 d | 8.5 ± 2.1 d | ||
30 MBq / 2.0μg | 12 Gy | 30 d | 7.9 ± 1.9 d | 0.10 | 2.7 d |
30 MBq / 1.0μg | 14 Gy | 44 d | 10.0 ± 3.0 d | 0.14 | 7.1 d |
30 MBq / 0.5μg | 18 Gy | 67 d | 9.1± 2.9 d | 0.14 | 3.5 d |
2x13 MBq/0.35μg | 2 x 6 Gy | 41 d | 6.1 ± 3.7 d | 0.19 | 6.1 d |
26 MBq/0.7μg | 12 Gy | 37 d | 6.4 ± 2.4 d | 0.18 | 3.9 d |
Control 2 | Saline | 32 d | 6.1 ± 2.3 d | ||
30 MBq / 0.8μg | 14 Gy | 53 d | 8.1 ± 3.0 d | 0.11 | 0.9 d |
2x30 MBq / 0.8μg | 2 x 14 Gy | 74 d | 8.2 ± 3.6 d | 0.10 | 3.1 d |